About the Program
Our program has two components: Hematopathology fellowship and Advanced Hematopathology fellowship. Hematopathology fellowship is a one year long ACGME accredited program, completion of which fulfills the requirements for Board certification in Hematopathology. Advanced Hematopathology fellowship is a one year long non-accredited program, which is designed to create a solid academic foundation and further improve diagnostic skills. Being a part of one of the largest academic centers in the World, we believe that our fellows benefit dramatically from completion of both programs and most of our fellow who completed both years have obtained excellent academic hematopathology positions. As a result we prefer candidates who make a two year commitment. However, we do make exceptions and in the past have accepted candidates desiring to complete only the one year Hematopathology fellowship. Therefore, strong candidates desiring to complete only Hematopathology fellowship are also encouraged to apply.
During one year, the department of Hematopathology at The University of Texas MD Anderson Cancer Center receives about 18,000 bone marrow specimens and 4,000 lymph node and other tissue specimens and performs 60,000 cytogenetic tests, 80,000 molecular diagnostic tests, and 18,000 flow cytometry immunophenotypic studies. This volume, combined with about 30 dedicated and experienced faculty members, provides a unique learning environment and opportunities for translational research.
The fellow is expected to become proficient in the clinical and laboratory evaluation of pathologic materials such as blood, bone marrow and lymph nodes. He/she will be expected to obtain knowledge in the use of instruments and equipment required for diagnostic laboratory studies and in the management of a hematology laboratory. The fellow is expected to improve knowledge and skills in light and fluorescent microscopy, bone marrow biopsy, immunohematology, molecular diagnosis, immunophenotyping and tissue culture techniques, cytogenetics, histochemistry, cytochemistry and immunocytochemistry. The experience in coagulation includes exposure to procedures used in the coagulation laboratory and clinical training in diagnosis, management and treatment of patients with coagulation disorders. In addition, the fellow will gain exposure to molecular biology as it pertains to hematologic diseases. Although the program is designed to provide experience and understanding in the special field of hematology, fellows will be encouraged to participate in the other teaching programs of the Divisions of Laboratory Medicine and Pathology.
For More Information
Sergej Konoplev, M.D., Ph.D.
Director, Hematopathology Fellowship Program
Department of Hematopathology
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 0072
Houston, TX 77030-4905
For additional information, please contact:
Dalia Miranda - Program Coordinator